No evidence for the presence of poor metabolizers of sparteine in an Amerindian group: the Cunas of Panama [letter]
1986; Wiley; Volume: 21; Issue: 5 Linguagem: Inglês
10.1111/j.1365-2125.1986.tb02841.x
ISSN1365-2125
Autores Tópico(s)Plant and fungal interactions
ResumoBritish Journal of Clinical PharmacologyVolume 21, Issue 5 p. 547-548 Free Access No evidence for the presence of poor metabolizers of sparteine in an Amerindian group: the Cunas of Panama [letter] TD Arias, TD AriasSearch for more papers by this authorLF Jorge, LF JorgeSearch for more papers by this authorT Inaba, T InabaSearch for more papers by this author TD Arias, TD AriasSearch for more papers by this authorLF Jorge, LF JorgeSearch for more papers by this authorT Inaba, T InabaSearch for more papers by this author First published: May 1986 https://doi.org/10.1111/j.1365-2125.1986.tb02841.xCitations: 5AboutReferencesRelatedInformationPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessClose modalShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References Barrantes, R., Smouse, P. E., Neel, J. V., Mohrenweiser, H. W. & Gershowitz, H. (1982). Migration and genetic infrastructure of the Central American Guaymi and their affinities with other tribal groups. Am. J. Phys. Anthrop., 58, 201– 214. Eichelbaum, M. (1982). Defective oxidation of drugs: pharmacokinetic and therapeutic implications. Clin. Pharmacokin., 7, 1– 22. Eichelbaum, M., Spannbrucker, N., Steincke, B. & Dengler, H J (1979). Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur. J. clin. Pharmac., 16, 183– 187. Eichelbaum, M. & Woolhouse, N M (1985). Interethnic difference in sparteine oxidation among Ghanaians and Germans. Eur. J. clin. Pharmac., 28, 79– 83. Evans, D. A. P., Harmer, D., Downham, D. Y., Whibley, E. J., Idle, J. R. Ritchie, J. & Smith, R L (1983). The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J. med. Genet., 20, 321– 329. Inaba, T., Vinks, A., Otton, S V & Kalow, W. (1983) Comparative pharmacogenetics of sparteine and debrisoquine. Clin. Pharmac. Ther., 33, 394– 399. Rodriguez, N. & Soubie, E. (1978). La poblacion indigena actual en America Latina. Nueva Antro- pologia, 3, 49. Torres de Araúz, R. (1980). Panama indigena. Panama: Instituto National de Cultura, 80, 105. Citing Literature Citation StatementsbetaSmart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by Wiley Online Library if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.SupportingSupporting0MentioningMentioning3ContrastingContrasting0Explore this article's citation statements on scite.aipowered by Volume21, Issue5May 1986Pages 547-548 Citation StatementsbetaSmart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by Wiley Online Library if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.SupportingSupporting0MentioningMentioning3ContrastingContrasting0Explore this article's citation statements on scite.aipowered by ReferencesRelatedInformation RecommendedQuinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.CJ Speirs, S Murray, AR Boobis, CE Seddon, DS Davies, British Journal of Clinical PharmacologyThe metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism.T Ebner, M Eichelbaum, British Journal of Clinical PharmacologyEvidence for polymorphic oxidation of sparteine in Japanese subjects.T Ishizaki, M Eichelbaum, Y Horai, K Hashimoto, K Chiba, HJ Dengler, British Journal of Clinical PharmacologyZiprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizersK. D. Wilner, S. B. Demattos, R. J. Anziano, G. Apseloff, &, N. Gerber, British Journal of Clinical PharmacologyThe influence of enzyme induction on polymorphic sparteine oxidation.M Eichelbaum, S Mineshita, EE Ohnhaus, C Zekorn, British Journal of Clinical Pharmacology
Referência(s)